糖皮质激素受体中的分子开关:活性和被动拮抗剂构象。

Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations.

机构信息

F Hoffmann-La Roche Ltd, Pharma Research, Discovery Technologies, Grenzacherstrasse 124, CH-4070 Basel, Switzerland.

出版信息

J Mol Biol. 2010 Jan 22;395(3):568-77. doi: 10.1016/j.jmb.2009.11.011. Epub 2009 Nov 11.

Abstract

Mifepristone is known to induce mixed passive antagonist, active antagonist, and agonist effects via the glucocorticoid receptor (GR) pathway. Part of the antagonist effects of mifepristone are due to the repression of gene transcription mediated by the nuclear receptor corepressor (NCoR). Here, we report the crystal structure of a ternary complex of the GR ligand binding domain (GR-LBD) with mifepristone and a receptor-interacting motif of NCoR. The structures of three different conformations of the GR-LBD mifepristone complex show in the oxosteroid hormone receptor family how helix 12 modulates LBD corepressor and coactivator binding. Differences in NCoR binding and in helix 12 conformation reveal how the 11beta substituent in mifepristone triggers the helix 12 molecular switch to reshape the coactivator site into the corepressor site. Two observed conformations exemplify the active antagonist state of GR with NCoR bound. In another conformation, helix 12 completely blocks the coregulator binding site and explains the passive antagonistic effect of mifepristone on GR.

摘要

米非司酮通过糖皮质激素受体(GR)途径已知诱导混合的被动拮抗剂、主动拮抗剂和激动剂作用。米非司酮的部分拮抗剂作用归因于核受体共抑制因子(NCoR)介导的基因转录的抑制。在这里,我们报告了 GR 配体结合域(GR-LBD)与米非司酮和 NCoR 的受体相互作用基序的三元复合物的晶体结构。三种不同构象的 GR-LBD 米非司酮复合物的结构显示了在甾醇激素受体家族中,螺旋 12 如何调节 LBD 共抑制因子和共激活因子结合。NCoR 结合和螺旋 12 构象的差异揭示了米非司酮的 11β取代基如何触发螺旋 12 分子开关,将共激活因子位点重塑为共抑制因子位点。两种观察到的构象例证了与 NCoR 结合的 GR 的活性拮抗剂状态。在另一种构象中,螺旋 12 完全阻止了共调节剂结合位点,并解释了米非司酮对 GR 的被动拮抗作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索